BackBiocept Overview

Biocept Current Assets

Biocept's current assets is $8.9M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$8.86M
79.76% YoYΔ $-34.92M vs prior year quarter

Peer average

Loading

Biocept Current Assets History

Loading

Biocept vs. peers: Current Assets Comparison

Loading

Biocept Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Biocept (BIOC) FAQ

Biocept (BIOC) currently reports a current assets of $8.9M as of June 2023. That compares with $44M in the prior-year period — down 79.8% year over year. Use the charts on this page to explore Biocept's current assets history and peer comparisons.

Biocept's current assets decreased from $44M to $8.9M — a 79.8% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biocept reported $8.9M in current assets as of June 2023. That compares with $44M in the prior-year period — down 79.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $8.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biocept, and consider following BIOC for alerts when major investors trade the stock.

Biocept is classified in the Healthcare sector. On current assets, it currently shows $8.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIOC with unrelated industries.